Hualan Biological Engineering Inc (SZSE:002007) Share Price

Company Profile

Business description
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, recombinant proteins, and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin, and others. The vaccine products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine, and others. It also offers gene products such as Monoclonal Antibodies for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Contact
No. 1, Hualan Avenue
Henan Province
Xinxiang453003
CHN
T: +86 3733559989
http://www.hualanbio.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
4,117

Recommended

The e-commerce business continues its sales momentum despite challenging backdrop.

Johannes Faul, CFA | 28 May 2026

Iran War disruptions drive thermal coal and aluminum prices higher but value to be found in other pockets.

Simonelle Mody | 27 May 2026

The mechanics behind inflation resilient ASX businesses.

Tyger Fitzpatrick | 27 May 2026

Index	Last price	Change	% Change
All Ordinaries	8,805.30	79.40	-0.89%
CAC 40	8,207.89	34.78	0.43%
DAX 40	25,177.80	7.09	-0.03%
Dow JONES (US)	50,644.28	182.60	0.36%
FTSE 100	10,505.01	13.62	0.13%
HKSE	24,748.65	579.58	-2.29%
NASDAQ	26,674.73	18.55	0.07%
Nikkei 225	64,218.17	781.24	-1.20%
NZX 50 Index	13,225.22	2.59	-0.02%
S&P 500	7,520.36	1.24	0.02%
S&P/ASX 200	8,578.90	75.60	-0.87%
SSE Composite Index	4,087.86	5.87	-0.14%